{"id":"https://openalex.org/W1146916630","doi":null,"title":"Development of Bioerodible Sustained Release Brimonidine Intraocular Device","display_name":"Development of Bioerodible Sustained Release Brimonidine Intraocular Device","publication_year":2010,"publication_date":"2010-04-17","ids":{"openalex":"https://openalex.org/W1146916630","mag":"1146916630"},"language":"en","primary_location":{"id":"mag:1146916630","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2371807","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084232534","display_name":"Hongshuang Guo","orcid":"https://orcid.org/0000-0003-3503-1774","observed_orcids":["https://orcid.org/0000-0003-3503-1774"]},"institutions":[{"id":"https://openalex.org/I4210139592","display_name":"EyePoint Pharmaceuticals (United States)","ror":"https://ror.org/03vwrbq09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139592"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongshuang Guo","raw_affiliation_strings":["pSivida Inc, Watertown, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0003-3503-1774","affiliations":[{"raw_affiliation_string":"pSivida Inc, Watertown, Massachusetts","institution_ids":["https://openalex.org/I4210139592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031882392","display_name":"J. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139592","display_name":"EyePoint Pharmaceuticals (United States)","ror":"https://ror.org/03vwrbq09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139592"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Chen","raw_affiliation_strings":["pSivida Inc, Watertown, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pSivida Inc, Watertown, Massachusetts","institution_ids":["https://openalex.org/I4210139592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011028407","display_name":"Gra\u017cyna Cynkowska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139592","display_name":"EyePoint Pharmaceuticals (United States)","ror":"https://ror.org/03vwrbq09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139592"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gra\u017cyna Cynkowska","raw_affiliation_strings":["pSivida Inc, Watertown, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pSivida Inc, Watertown, Massachusetts","institution_ids":["https://openalex.org/I4210139592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068904247","display_name":"Tadeusz Cynkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139592","display_name":"EyePoint Pharmaceuticals (United States)","ror":"https://ror.org/03vwrbq09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139592"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tadeusz Cynkowski","raw_affiliation_strings":["pSivida Inc, Watertown, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pSivida Inc, Watertown, Massachusetts","institution_ids":["https://openalex.org/I4210139592"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111388750","display_name":"Sunil P. Deokule","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunil Deokule","raw_affiliation_strings":["Department of Ophthamology, University of Kentucky, Lexington, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthamology, University of Kentucky, Lexington, Kentucky","institution_ids":["https://openalex.org/I143302722"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05754375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"51","issue":"13","first_page":"3165","last_page":"3165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brimonidine","display_name":"brimonidine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.949999988079071},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.7419999837875366},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C2778190193","wikidata":"https://www.wikidata.org/wiki/Q577377","display_name":"Brimonidine","level":3,"score":0.9544354677200317},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.39478734135627747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3881017863750458},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.11987310647964478}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1146916630","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2371807","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1009488191","https://openalex.org/W2994236874","https://openalex.org/W966414975","https://openalex.org/W2994402058","https://openalex.org/W756523062","https://openalex.org/W3009641814","https://openalex.org/W2578010492","https://openalex.org/W999078757","https://openalex.org/W3038425940","https://openalex.org/W2992411218"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}